FDA Clearance Tracker · K233964
GI Genius Module 100 (GGM100.US); GI Genius Module 200 (GGM200.US); ColonPRO 4.0 (CPRO40.US)
Last checked: Nov 20, 2026Latest source record: Jan 12, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jan 12, 2024
Substantially Equivalent
Time to decision
28 days
Received Dec 15, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K233964
- Device name
- GI Genius Module 100 (GGM100.US); GI Genius Module 200 (GGM200.US); ColonPRO 4.0 (CPRO40.US)
- Applicant location
- Dublin, IE
- Received
- Dec 15, 2023
- Decided
- Jan 12, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.1520
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QNP. The earliest in FDA's data is DEN200055, decided Apr 9, 2021.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K233964
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Cosmo Artificial Intelligence - Ai, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261369 · Decided May 29, 2026 · 32 days after receipt
Device type: Gastrointesinal Lesion Software Detection System (QNP) · GI, Urology & Nephrology
K241887 · Decided Jul 25, 2024 · 27 days after receipt
Device type: Gastrointesinal Lesion Software Detection System (QNP) · GI, Urology & Nephrology
K231143 · Decided May 19, 2023 · 28 days after receipt
Device type: Gastrointesinal Lesion Software Detection System (QNP) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.